PMCH and osteoporosis: To investigate the effect and therapeutic potential of MCHR1 signaling in skeletal senescence, we intravenously delivered both MCHR1 agonist (MCH TFA) and antagonist (ALB‐127158a) or vehicle (saline) for age induced osteoporosis in mice (Figure7A).